Intravas 4000 Anti-Xa IU/0.4 ml (SC Injection)
0.4 ml pre-filled syringe: ৳ 400.00
Medicine Details
Category | Details |
---|---|
Generic | Enoxaparin sodium |
Company | Aristopharma ltd |
Also available as |
Indications
- Treatment of deep vein thrombosis, with or without pulmonary embolism
- Treatment of unstable angina and non-Q-wave myocardial infarction
- Prevention of thrombus formation in the extra-corporeal circulation during haemodialysis
- Prophylaxis of venous thromboembolic disease in surgical patients
- Prophylaxis of venous thromboembolic disease in medical patients
Composition
- Enoxaparin Sodium BP 20 mg equivalent to 2000 anti-Xa III
- Enoxaparin Sodium BP 40 mg equivalent to 4000 anti-Xa III
- Enoxaparin Sodium BP 60 mg equivalent to 6000 anti-Xa IU
- Enoxaparin Sodium BP 80 mg equivalent to 8000 anti-Xa IU
Pharmacology
- Low molecular weight heparin with high anti-Xa activity
- Low anti-lla or antithrombin activity
- No notable modification of activated Partial Thromboplastin Time (aPTT)
Dosage
- Subcutaneously 100 anti-Xa IU/kg twice daily for 10 days
- Subcutaneously 150 anti-Xa IU/kg once daily for 10 days
- Subcutaneously 100 anti-Xa IU/kg twice daily for 2-8 days
Administration
- Injectable by deep subcutaneous route
- Should not be administered by the intramuscular route
- Injection site preparation steps
Interaction
Discontinue agents affecting hemostasis prior to therapy
Contraindications
- Known hypersensitivity to Enoxaparin Sodium, heparin or other low molecular weight heparins
- Active major bleeding
- High risk of uncontrolled hemorrhage
Side Effects
- Haemorrhage (bleeding)
- Thrombocytopenia
- Elevations of serum aminotransferase
Pregnancy & Lactation
- Category B (no evidence of crossing placental barrier)
- Use during pregnancy only if clearly needed
- Unknown excretion in human milk
Precautions & Warnings
- Use with caution in conditions with increased potential for bleeding
- Regular platelet count measurements
Use in Special Populations
- Elderly patients dosage
- Dose adjustments in renal impairment
- Caution in hepatically impaired patients
Overdose Effects
Accidental overdosage may lead to hemorrhagic complications
Therapeutic Class
Parenteral anti-coagulants
Storage Conditions
Store in a cool and dry place, protect from light and moisture
Related Brands
- Cardinex 4000 Anti-Xa IU/0.4 ml (SC Injection) - drug-international-ltd
- Cardinex 6000 Anti-Xa IU/0.6 ml (SC Injection) - drug-international-ltd
- Claxo 6000 Anti-Xa IU/0.6 ml (SC Injection) - general-pharmaceuticals-ltd
- Cleven 2000 Anti-Xa IU/0.2 ml (SC Injection) - beximco-pharmaceuticals-ltd
- Cleven 4000 Anti-Xa IU/0.4 ml (SC Injection) - beximco-pharmaceuticals-ltd